Your browser doesn't support javascript.
loading
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Kumar, Shaji K; Callander, Natalie S; Adekola, Kehinde; Anderson, Larry D; Baljevic, Muhamed; Campagnaro, Erica; Castillo, Jorge J; Costello, Caitlin; D'Angelo, Christopher; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C; Liedtke, Michaela; Martin, Thomas; Omel, James; Rosenberg, Aaron; Sborov, Douglas; Valent, Jason; Berardi, Ryan; Kumar, Rashmi.
Affiliation
  • Kumar SK; Mayo Clinic Cancer Center.
  • Callander NS; University of Wisconsin Carbone Cancer Center.
  • Adekola K; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Anderson LD; UT Southwestern Simmons Comprehensive Cancer Center.
  • Baljevic M; Vanderbilt-Ingram Cancer Center.
  • Campagnaro E; University of Michigan Rogel Cancer Center.
  • Castillo JJ; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center.
  • Costello C; UC San Diego Moores Cancer Center.
  • D'Angelo C; Fred & Pamela Buffett Cancer Center.
  • Devarakonda S; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Elsedawy N; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
  • Garfall A; Abramson Cancer Center at the University of Pennsylvania.
  • Godby K; O'Neal Comprehensive Cancer Center at UAB.
  • Hillengass J; Roswell Park Comprehensive Cancer Center.
  • Holmberg L; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Htut M; City of Hope National Medical Center.
  • Huff CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Hultcrantz M; Memorial Sloan Kettering Cancer Center.
  • Kang Y; Duke Cancer Institute.
  • Larson S; UCLA Jonsson Comprehensive Cancer Center.
  • Lee HC; The University of Texas MD Anderson Cancer Center.
  • Liedtke M; Stanford Cancer Institute.
  • Martin T; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Omel J; Patient advocate.
  • Rosenberg A; UC Davis Comprehensive Cancer Center.
  • Sborov D; Huntsman Cancer Institute at the University of Utah.
  • Valent J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Berardi R; National Comprehensive Cancer Network.
  • Kumar R; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 21(1): 67-81, 2023 01.
Article in En | MEDLINE | ID: mdl-36652935
Primary systemic light chain amyloidosis (SLCA) is characterized by production of light chains that get converted to amyloid fibrils with an affinity for visceral organs and causing organ dysfunction. The therapy for SLCA is directed to recovering the function of the affected organs by targeting the abnormal plasma cell clone and slowing deposition of amyloid fibrils. The NCCN Guidelines for SLCA provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated SLCA.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid / Amyloidosis Type of study: Diagnostic_studies / Etiology_studies / Guideline Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid / Amyloidosis Type of study: Diagnostic_studies / Etiology_studies / Guideline Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2023 Type: Article